Literature DB >> 2539306

Treatment with 16,16'-dimethyl prostaglandin E2 before and after induction of colitis with trinitrobenzenesulfonic acid in rats decreases inflammation.

H Allgayer1, K Deschryver, W F Stenson.   

Abstract

Colitis was induced in rats by intrarectal administration of trinitrobenzene sulfonic acid (80 mg/kg, in 30% ethanol). An acute inflammation with ulcers and neutrophil infiltration developed that evolved into a chronic inflammation and luminal narrowing with attendant smooth muscle hypertrophy. We assessed the effects of 16,16-dimethyl prostaglandin E2, administered either before or after trinitrobenzene sulfonic acid, on the development of inflammation. Inflammation was assessed by gross appearance using a grading scale (0-4) and by histology. The number of neutrophils present in inflamed colonic tissue was quantitated by the myeloperoxidase assay. The production of lipoxygenase products was monitored by incubation of colonic specimens with [14C]arachidonic acid and separation of the products by thin-layer chromatography and high-pressure liquid chromatography. Levels of leukotriene B4 were measured in tissue extracts by high-pressure liquid chromatography and ultraviolet absorbance. Eicosanoid production was also assayed by incubating colonic specimens and assaying the media for prostaglandin E2, leukotriene B4, and leukotriene C4 by radioimmunoassay. Trinitrobenzene sulfonic acid treatment resulted in a greatly increased amount of leukotriene B4 in the media. Treatment with 16,16-dimethyl prostaglandin E2 before administration of trinitrobenzene sulfonic acid resulted in a lower inflammation index, lower myeloperoxidase activity, and decreased production of leukotriene B4. Administration of 16,16-dimethyl prostaglandin E2 24 h after administration of trinitrobenzene sulfonic acid was also effective in reducing the inflammatory response. Treatment with 16,16-dimethyl prostaglandin E2 also prevented the development of long-term architectural changes 3 wk after administration of trinitrobenzene sulfonic acid. Rectal administration of dimethyl prostaglandin E2 also diminished the colitis induced by direct injection of trinitrobenzene sulfonic acid into the colonic wall.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2539306     DOI: 10.1016/s0016-5085(89)80016-2

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  32 in total

1.  Drug-induced fibrosing colonopathy in inflammatory bowel disease after 5-ASA?

Authors:  H Allgayer; P Böhne; W Kruis
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

2.  Specific NF-kappaB blockade selectively inhibits tumour necrosis factor-alpha-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells.

Authors:  C Jobin; O Morteau; D S Han; R Balfour Sartor
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

Review 3.  Clinical relevance of oxygen radicals in inflammatory bowel disease--facts and fashion.

Authors:  H Allgayer
Journal:  Klin Wochenschr       Date:  1991-12-15

4.  Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor.

Authors:  M N Muscará; W McKnight; S Asfaha; J L Wallace
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

5.  Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2.

Authors:  O Morteau; S G Morham; R Sellon; L A Dieleman; R Langenbach; O Smithies; R B Sartor
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

6.  Atherogenic diet causes lethal ileo-ceco-colitis in cyclooxygenase-2 deficient mice.

Authors:  James A Lin; Junji Watanabe; Nora Rozengurt; Ajay Narasimha; Martin G Martin; Jenny Wang; Jonathan Braun; Robert Langenbach; Srinivasa T Reddy
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-04-25       Impact factor: 3.072

7.  Growth factor regulation of prostaglandin-endoperoxide synthase 2 (Ptgs2) expression in colonic mesenchymal stem cells.

Authors:  Monica R Walker; Sarah L Brown; Terrence E Riehl; William F Stenson; Thaddeus S Stappenbeck
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

8.  Experimental colitis alters visceromotor response to colorectal distension in awake rats.

Authors:  O Morteau; T Hachet; M Caussette; L Bueno
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

9.  Abnormal leukotriene C4 released by unaffected jejunal mucosa in patients with inactive Crohn's disease.

Authors:  F Casellas; F Guarner; M Antolín; R Rodríguez; A Salas; J R Malagelada
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

10.  Mucosal protective activity of prostaglandin analogs in rodent colonic inflammation.

Authors:  D J Fretland; D L Widomski; C P Anglin; R E Walsh; S Levin; A F Gasiecki; P W Collins
Journal:  Inflammation       Date:  1992-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.